Inovio Pharmaceuticals Elects Directors, Ratifies Auditors
Ticker: INO · Form: 8-K · Filed: May 28, 2024 · CIK: 1055726
| Field | Detail |
|---|---|
| Company | Inovio Pharmaceuticals, INC. (INO) |
| Form Type | 8-K |
| Filed Date | May 28, 2024 |
| Risk Level | low |
| Pages | 6 |
| Reading Time | 7 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, director-election, auditor-ratification
Related Tickers: INO
TL;DR
INOVIO shareholders elected new directors and approved the company's auditor for 2024.
AI Summary
On May 21, 2024, Inovio Pharmaceuticals, Inc. filed an 8-K report detailing a shareholder meeting held on May 20, 2024. The meeting included the election of two Class II directors, Dr. Niranjan Bose and Ms. Joanne Lord, to serve until the 2027 annual meeting. Additionally, shareholders voted on the ratification of the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024.
Why It Matters
The election of directors and ratification of auditors are routine but essential corporate governance actions that provide transparency and accountability to shareholders.
Risk Assessment
Risk Level: low — This filing concerns routine corporate governance matters such as director elections and auditor ratification, which typically carry low risk.
Key Players & Entities
- Inovio Pharmaceuticals, Inc. (company) — Registrant
- Dr. Niranjan Bose (person) — Elected Class II Director
- Ms. Joanne Lord (person) — Elected Class II Director
- PricewaterhouseCoopers LLP (company) — Independent Registered Public Accounting Firm
- May 21, 2024 (date) — Date of Report
- May 20, 2024 (date) — Date of Shareholder Meeting
- 2027 (date) — Director Term End Year
- December 31, 2024 (date) — Fiscal Year End for Auditor Ratification
FAQ
Who were elected as Class II directors at the Inovio Pharmaceuticals shareholder meeting?
Dr. Niranjan Bose and Ms. Joanne Lord were elected as Class II directors.
Until when are the newly elected Class II directors expected to serve?
The newly elected Class II directors are expected to serve until the 2027 annual meeting.
What was the purpose of the shareholder meeting on May 20, 2024?
The meeting was held for the election of directors and the ratification of the appointment of the independent registered public accounting firm.
Which accounting firm was ratified by shareholders?
PricewaterhouseCoopers LLP was ratified as the independent registered public accounting firm.
For which fiscal year was the appointment of the independent registered public accounting firm ratified?
The appointment of PricewaterhouseCoopers LLP was ratified for the fiscal year ending December 31, 2024.
Filing Stats: 1,823 words · 7 min read · ~6 pages · Grade level 12.6 · Accepted 2024-05-28 16:01:02
Key Financial Figures
- $0.001 — ange on which registered Common Stock, $0.001 par value INO The Nasdaq Stock Mark
Filing Documents
- d597714d8k.htm (8-K) — 50KB
- 0001193125-24-148076.txt ( ) — 173KB
- ino-20240521.xsd (EX-101.SCH) — 3KB
- ino-20240521_lab.xml (EX-101.LAB) — 18KB
- ino-20240521_pre.xml (EX-101.PRE) — 11KB
- d597714d8k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INOVIO PHARMACEUTICALS, INC. Date: May 28, 2024 By: /s/ Peter Kies Peter Kies Chief Financial Officer 4